Article
Merck's Keytruda meets main goal in late-stage breast cancer study
Rating:
0.0
Views:
63
Likes:
1
Library:
1
Merck said on Friday its blockbuster drug Keytruda, in combination with chemotherapy, met one of the main goals in a late-stage trial testing it in some breast cancer patients.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value